Beclomin Inhaler 250mcg/puff

Indication:

Beclometasone 250 HFA Inhaler is indicated in the prophylactic management of mild, moderate, or severe asthma in adults or

children.

Beclometasone dipropionate given by inhalation offers preventative treatment for asthma. It provides effective anti-inflammatory

action in the lungs with a

lower incidence and severity of adverse effects than those observed when corticosteroids are administered systemically.

Mild asthma :

Patients requiring symptomatic bronchodilator asthma medication on a regular basis.

Moderate asthma: Patients with unstable or worsening asthma despite prophylactic therapy

or

bronchodilator alone.

Severe asthma : Patients with severe chronic asthma and those who are dependent on systemic corticosteroids for adequate control

of symptoms. Many patients who are dependent on systemic corticosteroids for adequate control of symptoms may be able to reduce

significantly, or eliminate, their requirement for oral corticosteroids when they are transferred to high dose inhaled

beclometasone dipropionate.

Dosage & Administration:

Beclometasone dipropionate Inhaler is for oral inhalation use only. Patients should be given a starting dose of inhaled

beclometasone dipropionate appropriate to the severity of their disease. The dose may then be adjusted until control is achieved,

or reduced to the minimum effective dose according to individual response.

Adults (including the elderly): The usual starting dose is 200 micrograms twice a day. In more severe cases the starting dose may

need to increase to 600 to 800 micrograms per day which may then be reduced when the patient's asthma has stabilised. The total

daily dose may be administered as two, three, or four divided doses

Children: 50 to 100 micrograms should be given two, three or four times daily in accordance to the response. Alternatively, 100

micrograms or 200 micrograms twice daily should be given. The usual starting dose is 100 micrograms twice daily

Beclometasone 250 Inhaler is not recommended for children.

There is no need to increase the dose in patients with hepatic or renal impairment.

Beclometasone 250 HFA Inhaler: The usual starting dose is 200 micrograms twice a day. In more severe cases the starting dose may

need to increase to 600 to 800 micrograms per day which may then be reduced when the patient's asthma has stabilised. The total

daily dose may be administered as two, three, or four divided doses

Preparation:

Each Inhaler delivers 200 puffs.